The Relationship Between Diabetes and Colorectal Cancer Prognosis: A Meta-analysis Based on the Cohort Studies

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2017 Apr 20

PMID 28423026

Citations 62

Authors

Bo Zhu

Xiaomei Wu

Bo Wu

Dan Pei

Lu Zhang

Lixuan Wei

Affiliations

Soon will be listed here.

Abstract

Introduction: Though a meta-analysis reported the effect of diabetes on colorectal prognosis in 2013, a series of large-scale long-term cohort studies has comprehensively reported the outcome effect estimates on the relationship between diabetes and colorectal prognosis, and their results were still consistent.

Methods: We carried out an extensive search strategy in multiple databases and conducted a meta-analysis on the effect of diabetes on colorectal prognosis, based on the included 36 cohort studies, which contained 2,299,012 subjects. In order to collect more data, besides conventional methods, we used the professional software to extract survival data from the Kaplan-Meier curves, and analyzed both the 5-year survival rate and survival risk in overall survival, cancer-specific survival, cardiovascular disease-specific survival, disease-free survival, and recurrence-free survival, to comprehensively reflect the effect of diabetes on colorectal prognosis.

Results: The results found that compared to patients without diabetes, patients with diabetes will have a 5-year shorter survival in colorectal, colon and rectal cancer, with a 18%, 19% and 16% decreased in overall survival respectively. We also found similar results in cancer-specific survival, cardiovascular disease-specific survival, disease-free survival, and recurrence-free survival, but not all these results were significant. We performed the subgroup analysis and sensitivity analysis to find the source of heterogeneity. Their results were similar to the overall results.

Conclusions: Our meta-analysis suggested that diabetes had a negative effect on colorectal cancer in overall survival. More studies are still needed to confirm the relationship between diabetes and colorectal prognosis in cancer-specific survival, cardiovascular disease-specific survival, disease-free survival, and recurrence-free survival.

Citing Articles

Metabolic Conditions and Organ Dysfunctions Risk Factors for Gastrointestinal Cancer in Hypertensive Patients: A Case-Control Study in China.

Yang T, Cao C Cancer Manag Res. 2024; 16:1627-1638.

PMID: 39582796 PMC: 11583784. DOI: 10.2147/CMAR.S484790.

Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular traps.

Saito A, Koinuma K, Kawashima R, Miyato H, Ohzawa H, Horie H BJC Rep. 2024; 1(1):20.

PMID: 39516686 PMC: 11524073. DOI: 10.1038/s44276-023-00022-w.

Associations of diabetes and mortality among colorectal cancer patients from the Southern Community Cohort Study.

Lawler T, Hibler E, Walts Z, Giurini L, Steinwandel M, Lipworth L Br J Cancer. 2024; 131(6):1050-1059.

PMID: 39030444 PMC: 11405675. DOI: 10.1038/s41416-024-02787-4.

Associations between Diabetes Mellitus and Selected Cancers.

Pliszka M, Szablewski L Int J Mol Sci. 2024; 25(13).

PMID: 39000583 PMC: 11242587. DOI: 10.3390/ijms25137476.

High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.

Li F, Wan X, Li Z, Zhou L Cancer Med. 2024; 13(11):e7382.

PMID: 38872380 PMC: 11176572. DOI: 10.1002/cam4.7382.

References

Fransgaard T, Thygesen L, Gogenur I . Increased 30-day mortality in patients with diabetes undergoing surgery for colorectal cancer. Colorectal Dis. 2015; 18(1):O22-9. DOI: 10.1111/codi.13158. View

Liu D, Li Q, Yang Z, Hu X, Qian W, Du Y . Association of body mass index and smoking on outcome of Chinese patients with colorectal cancer. World J Surg Oncol. 2013; 11:271. PMC: 3853928. DOI: 10.1186/1477-7819-11-271. View

Shonka N, Anderson J, Panwalkar A, Reed E, Steen P, Ganti A . Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2007; 23(4):515-9. DOI: 10.1385/MO:23:4:515. View

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

Klil-Drori A, Azoulay L, Pollak M . Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?. Nat Rev Clin Oncol. 2016; 14(2):85-99. DOI: 10.1038/nrclinonc.2016.120. View

Lai C, You J, Yeh C, Chen J, Tang R, Wang J . Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Colorectal Dis. 2010; 26(4):473-81. DOI: 10.1007/s00384-010-1113-4. View

Zhu L, Dong C, Cao Y, Fang X, Zhong C, Li D . Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials. PLoS One. 2016; 11(5):e0154795. PMC: 4854379. DOI: 10.1371/journal.pone.0154795. View

Chen K, Shao Y, Lin Z, Yeh Y, Shau W, Kuo R . Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer. Oncologist. 2014; 19(9):951-8. PMC: 4153450. DOI: 10.1634/theoncologist.2013-0423. View

Walker J, Brewster D, Colhoun H, Fischbacher C, Lindsay R, Wild S . Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007). Diabetologia. 2013; 56(7):1531-41. DOI: 10.1007/s00125-013-2917-x. View

10.

Coughlin S, Calle E, Teras L, Petrelli J, Thun M . Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004; 159(12):1160-7. DOI: 10.1093/aje/kwh161. View

11.

Colangelo L, Gapstur S, Gann P, Dyer A, Liu K . Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev. 2002; 11(4):385-91. View

12.

Parmar M, Torri V, Stewart L . Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1999; 17(24):2815-34. DOI: 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8. View

13.

Tong L, Ahn C, Symanski E, Lai D, Du X . Temporal trends in the leading causes of death among a large national cohort of patients with colorectal cancer from 1975 to 2009 in the United States. Ann Epidemiol. 2014; 24(6):411-7. DOI: 10.1016/j.annepidem.2014.01.005. View

14.

Ramjeesingh R, Orr C, Bricks C, Hopman W, Hammad N . A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival. Curr Oncol. 2016; 23(2):e116-22. PMC: 4835004. DOI: 10.3747/co.23.2809. View

15.

Huang C, Sun L, Shih Y, Tsai H, Chen C, Yeh Y . The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer. World J Surg Oncol. 2012; 10:76. PMC: 3533895. DOI: 10.1186/1477-7819-10-76. View

16.

Paulus J, Williams C, Cossor F, Kelley M, Martell R . Metformin, Diabetes, and Survival among U.S. Veterans with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2016; 25(10):1418-1425. PMC: 5050110. DOI: 10.1158/1055-9965.EPI-16-0312. View

17.

van de Poll-Franse L, Haak H, Coebergh J, Janssen-Heijnen M, Lemmens V . Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia. 2012; 55(8):2163-72. PMC: 3390707. DOI: 10.1007/s00125-012-2555-8. View

18.

Polednak A . Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006; 30(5):466-72. DOI: 10.1016/j.cdp.2006.07.003. View

19.

Zhu B, Wu X, Bi Y, Yang Y . Effect of bilirubin concentration on the risk of diabetic complications: A meta-analysis of epidemiologic studies. Sci Rep. 2017; 7:41681. PMC: 5278382. DOI: 10.1038/srep41681. View

20.

Shaw J, Sicree R, Zimmet P . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009; 87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. View